Are you concerned about the long-term effects of Abilify? Like many antipsychotic medications, prescriptions can go on for years, and some adverse effects can begin to outweigh the benefits.
The good news is that there may be a better solution to symptoms of schizophrenia or bipolar conditions. Using safe, proven methods, we have helped thousands of clients to successfully reduce symptoms without having to rely on drug-based therapy.
Do Your Symptoms Require Long-Term Abilify?
Alternative to Meds Center has spent nearly 20 years assisting clients where prescription drugs such as antipsychotics have not delivered the treatment results that were hoped for. Many of our staff have emerged from similar difficulties themselves, understand the depths of the frustrations of our clients and we have experienced the joy and relief that recovery brings. Our documented success continues, giving hope to many suffering in quiet desperation and hopelessness. There is hope. We are here to help.
15 Years Experience by Professionals Who Understand Your Journey.
Why do people remain on Ability for a very long time?
Antipsychotics such as Abilify have been the subject of much research, spanning decades. This is fortunate because it offers the chance to draw on a substantial body of information that can help plan one’s future journey that for some, may benefit from more natural mental wellness strategies.
The eruption of a crisis situation such as mania or psychosis does not allow for much else than bringing the situation under control as quickly as possible. Abilify is prescribed for such reasons as to control mania, psychosis, agitation, and irritability in autism.6 It is not uncommon that a diagnosis may be imperfect during such a period of acute turbulence. Often, a prescription drug may have been the only practical choice at that time. However, after the crisis has passed, a more thorough assessment of all the factors involved may enable transitioning to other treatment methods moving forward. It is quite common, however, that once a diagnosis is made and a prescription is initiated, no further investigation is done. In fact, long-term use of antipsychotic medication has become the immovable cornerstone of treatment for schizophrenia despite the APA suggesting that when the patient has stabilized, discontinuing treatment with antipsychotics should be considered.2 A person may thus end up continuing to take medication for a very long time, despite having achieved adequate stabilization or remission of symptoms.
What are the Long-Term Effects of Abilify?
From quite a large body of information, we can clearly observe some of the common as well as rare long-term effects of Abilify that have been reported over many years.2,3,5-9 Further in this piece, we will discuss possible reasons that have been cited for why some of these adverse effects come about. Not every person has the same experience as others while taking a prescription drug, and some studies show contrasting results that remain poorly understood.
It is commonly reported in the medical literature that in schizophrenia patients, antipsychotics are associated with less likelihood of relapse, within a threshold of 1-3 years. However, after this duration of drug-based therapy, positive outcomes are less clear.5,19
For example, one 20-year-long study out of Chicago found 92% of the unmedicated persons had no symptoms of psychosis, compared to 68% of the participants who still suffered symptoms of psychosis after 20 years of continuous medication.20
A 14-year study out of rural China involving over 123,000 patients noted that those who had access to medication did “substantially better” than those who with no access to medication. However, the study also notes that those who had no access to medication were significantly older, with significantly fewer family members, or lived alone, and were more likely to be homeless, without access to caregivers or other types of mental health care. Without more details from observations of the patients, it becomes difficult to select preferred protocols for treatment.10
The following is a partial list of potential adverse effects associated with Abilify as given on the drug’s label information as well as from other sources as indicated.1
Long-term effects of Abilify may include:
Changes in brain volume11
Dopamine supersensitivity, associated with psychosis and other adverse effects24
Newly emergent suicidality14
Feelings of self-doubt, emotional numbing, and social withdrawal27
Weight gain, other metabolic dysfunction including diabetes (though to a lesser extent than some other antipsychotics)1,25
Insomnia
Anxiety
Declining efficacy after long-term, continuous antipsychotic treatment9,19
Clinical worsening after long-term use9,20
Extrapyramidal effects (involuntary movement disorders) such as tardive dyskinesia, NMS, and others.
Covert dyskinesia — a form of movement disorder that may emerge after cessation of Abilify13
Adverse effects on the heart, and adverse effects on blood pressure
Conditions relating to low white blood cell count such as leukopenia
Sedation
Akinesia (lack of movement)
Akathisia (compulsive movement)14
Compulsive gambling, sexuality, and other uncharacteristic behaviors1,12
Stroke or other cardiovascular events in elderly dementia patients
Can Abilify Long-Term Effects Change Brain Structure?
Regarding changes in brain tissue volume, the results of clinical studies are equally baffling with some persons experiencing loss of brain volume after medication, or brain volume increasing in other areas of the brain, and not in all cases but in some cases, this was associated with mental decline. These long-term studies on brain volume cannot be considered conclusive due to their inconsistent outcomes, but suggest that antipsychotic medication may change the structure of the human brain in ways that are poorly understood.11 In summary, it can be determined that some persons did better when continuously medicated, and some did better remaining unmedicated, or after reducing or eliminating medication. These inconsistencies underscore the importance of individualized treatment decisions, based on carefully assessing the needs and circumstances of each unique person.
Whether a drug changes brain volume or not, many other factors should be included in designing the best individual treatment protocols for the best outcomes possible. There should never be a one-size-fits-all approach that can be considered equally effective for all. Time, observation, and testing are some of the things that are needed to determine the best approach for each individual in the planning of a path to recovery.
Cannabis-Induced Psychosis and Misdiagnosis
A common occurrence in some medical crises is a misdiagnosis of schizophrenia after an episode of drug-induced psychosis. Cannabis has become one of the most widely used recreational drugs today. A misdiagnosis after a drug-induced psychotic episode can lead to incorrect treatments and cascading harm that can be long-lasting. If a prescription of Abilify was given, it may become difficult to differentiate the long-term effects of Abilify from other causality factors.15
Of note, recreational cannabis use in society is on a steep incline, with access to much more potent products than ever before. As opposed to medical marijuana, the recreational use of cannabis increases the risk of drug-induced episodes of psychosis. In today’s world where cannabis has become popularized within the mainstream, this phenomenon may become more prevalent as time goes on.
The prevalence of recreational cannabis use suggests a growing number of persons may be diagnosed as “schizophrenic” when in fact the person experienced drug-induced psychosis. According to a Lancet review, compared to non-users, a 5-fold increase in psychotic episodes was found associated with daily use of high-THC content cannabis.16
Also important to note, for persons who do suffer from schizophrenia or similar conditions, cannabis use should be altogether avoided as it has been shown to exacerbate symptoms and may trigger a relapse.17
An interesting study published in the International Review of Neurobiology has reported that a certain dysfunctional cannabinoid receptor, CB1, is suggested as a contributing factor in schizophrenia from postmortem, genetic, and other studies. Though more analysis is needed, the suggested relationship is a fascinating one and researchers are hopeful that it may lead to more effective treatment in the future, potentially avoiding unwanted long-term effects of Abilify and other antipsychotic drugs.18
Are Safer Treatments Available to Avoid the Long-Term Effects of Abilify?
The good news is that there are many treatment methods that can help reduce or eliminate unwanted symptoms, that may outperform long-term drug-based therapy. Alternative to Meds provides natural treatments tailored to each client’s unique profile.
Natural mental health therapies have provided a broad base of evidence-based treatment options that may help avoid the long-term adverse effects of medication. Alternative to Meds has been the leader for decades in the domain of natural therapies for mental health and we are thrilled to see such trends now clearly emerging and taking their rightful place in mainstream medicine.4,26
*A note about holistic detox: it is imperative that the safest way to reduce antipsychotic medication requires a very slow process. Dopamine supersensitivity is thought to be the reason for many problems that may be encountered if the process is done too fast, such as rebound psychosis, or an uncontrollable psychotic episode. Much like taking the brakes off while descending down a steep and slippery hill, the reduction must be very gradual, and very closely monitored to avoid an out-of-control situation from developing. Safe gradual cessation is the safest route.24
Find Out About Natural Mental Health Treatment at Alternative to Meds Center
For about 20 years now, Alternative to Meds Center has been the foremost holistic treatment center in the world offering inpatient natural mental health treatment. Please take some time to review the treatments offered by browsing through our services overview pages to get a more detailed description of the broad range of therapies available to our clients. We have the resources you or your loved one may have been searching for all under one roof, right here nestled at the foot of the majestic red rocks of Sedona. Please call and speak to us about your treatment goals and other questions you may have about insurance coverage, the length of the program, and any other areas you would like to know more about. Our treatment protocols are designed for each unique client, and may well be the key to recovery from the long-term effects of Abilify and lingering symptoms, without relying solely on prescription drugs.
6. Gettu N, Saadabadi A. Aripiprazole. [Updated 2022 May 21]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK547739/ [cited 2023 Jan 2]
15. Bacon A, Granholm E, Withers N. Substance-Induced Psychosis. Semin Clin Neuropsychiatry. 1998 Jan;3(1):70-79. PMID: 10085193. [cited 2023 Jan 2]
16. Hasan A, von Keller R, Friemel CM, Hall W, Schneider M, Koethe D, Leweke FM, Strube W, Hoch E. Cannabis use and psychosis: a review of reviews. Eur Arch Psychiatry Clin Neurosci. 2020 Jun;270(4):403-412. doi: 10.1007/s00406-019-01068-z. Epub 2019 Sep 28. PMID: 31563981. [cited 2023 Jan 2]
17. Di Forti M, Quattrone D, Freeman TP, Tripoli G, Gayer-Anderson C, Quigley H, Rodriguez V, Jongsma HE, Ferraro L, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szöke A, Arango C, Tortelli A, Velthorst E, Bernardo M, Del-Ben CM, Menezes PR, Selten JP, Jones PB, Kirkbride JB, Rutten BP, de Haan L, Sham PC, van Os J, Lewis CM, Lynskey M, Morgan C, Murray RM; EU-GEI WP2 Group. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. Lancet Psychiatry. 2019 May;6(5):427-436. doi: 10.1016/S2215-0366(19)30048-3. Epub 2019 Mar 19. PMID: 30902669; PMCID: PMC7646282. [cited 2023 Jan 2]
18. Sewell RA, Ranganathan M, D’Souza DC. Cannabinoids and psychosis. Int Rev Psychiatry. 2009 Apr;21(2):152-62. doi: 10.1080/09540260902782802. PMID: 19367509. [cited 2023 Jan 2]
22. Samochowiec J, Misiak B. Gut microbiota and microbiome in schizophrenia. Curr Opin Psychiatry. 2021 Sep 1;34(5):503-507. doi: 10.1097/YCO.0000000000000733. PMID: 34155149. [cited 2023 Jan 2]
Originally Published January 3, 2023 by Diane Ridaeus
This content has been reviewed and approved by a licensed physician.
Dr. Samuel Lee
Dr. Samuel Lee is a board-certified psychiatrist, specializing in a spiritually-based mental health discipline and integrative approaches. He graduated with an MD at Loma Linda University School of Medicine and did a residency in psychiatry at Cedars-Sinai Medical Center and University of Washington School of Medicine in Seattle. He has also been an inpatient adult psychiatrist at Kaweah Delta Mental Health Hospital and the primary attending geriatric psychiatrist at the Auerbach Inpatient Psychiatric Jewish Home Hospital. In addition, he served as the general adult outpatient psychiatrist at Kaiser Permanente. He is board-certified in psychiatry and neurology and has a B.A. Magna Cum Laude in Religion from Pacific Union College. His specialty is in natural healing techniques that promote the body’s innate ability to heal itself.
Diane is an avid supporter and researcher of natural mental health strategies. Diane received her medical writing and science communication certification through Stanford University and has published over 3 million words on the topics of holistic health, addiction, recovery, and alternative medicine. She has proudly worked with the Alternative to Meds Center since its inception and is grateful for the opportunity to help the founding members develop this world-class center that has helped so many thousands regain natural mental health.
Medical Disclaimer: Nothing on this Website is intended to be taken as medical advice. The information provided on the website is intended to encourage, not replace, direct patient-health professional relationships. Always consult with your doctor before altering your medications. Adding nutritional supplements may alter the effect of medication. Any medication changes should be done only after proper evaluation and under medical supervision.
Our Success Stories
Medication Withdrawal Success Stories
Can you imagine being free from medications, addictive drugs, and alcohol? This is our goal and we are proving it is possible every day!
The eruption of a crisis situation such as mania or psychosis does not allow for much else than bringing the situation under control as quickly as possible. Abilify is prescribed for such reasons as to control mania, psychosis, agitation, and irritability in autism.6 It is not uncommon that a diagnosis may be imperfect during such a period of acute turbulence. Often, a prescription drug may have been the only practical choice at that time. However, after the crisis has passed, a more thorough assessment of all the factors involved may enable transitioning to other treatment methods moving forward. It is quite common, however, that once a diagnosis is made and a prescription is initiated, no further investigation is done. In fact, long-term use of antipsychotic medication has become the immovable cornerstone of treatment for schizophrenia despite the APA suggesting that when the patient has stabilized, discontinuing treatment with antipsychotics should be considered.2 A person may thus end up continuing to take medication for a very long time, despite having achieved adequate stabilization or remission of symptoms.
Changes in brain volume 11
Of note, recreational cannabis use in society is on a steep incline, with access to much more potent products than ever before. As opposed to medical marijuana, the recreational use of cannabis increases the risk of drug-induced episodes of psychosis. In today’s world where cannabis has become popularized within the mainstream, this phenomenon may become more prevalent as time goes on.
Gradual, safe 
